1Jan Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease Posted by: admin Categories: Idiopathic Pulmonary Fibrosis Comments Off on Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease <br /> Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease – Fingerprint<br /> — University of Edinburgh Research Explorer Sort by Weight Alphabetically Medicine & Life Sciences nintedanib 100% Interstitial Lung Diseases 68% Placebos 43% Randomized Controlled Trials 42% Vital Capacity 41% Child 27% Pulmonary Arterial Hypertension 14% Standard of Care 12% Liver Diseases 10% Pharmacokinetics 9% Fibrosis 9% Chronic Disease 9% Cardiovascular Diseases 9% Oxygen 8% Body Weight 8% Tomography 8% Hemorrhage 8% Quality of Life 8% Pediatrics 8% Safety 7% Source link
